Zimmer upgraded to Buy from Neutral at Summer Street Summer Street upgraded Zimmer to Buy with a $133 price target citing the proposed acquisition of Biomet. The firm recommends using any weakness from the Q2 earnings report as a buying opportunity.
Zimmer Acquires bone void filler maker ETEX Holdings Zimmer Holdings announced that it has acquired the business of ETEX Holdings. The financial terms of the transaction were not disclosed. The acquisition enhances Zimmer's Biologics portfolio of treatments through the addition of ETEX's Beta-bsm, CarriGen, EquivaBone, and Gamma-bsm bone void filler products.